TMEM16A调节了呼吸道疾病中MUC5AC的产生:一个全面的审查
Jintao Gan1, Xiaochun Huang1, Danli Zhu1
1Department of Anesthesiology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, China; Anesthesiology and Critical Care Medicine Key Laboratory of Luzhou, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, China.
Current opinion in pharmacology
|January 13, 2026
概括
跨膜蛋白16A (TMEM16A) 调节气道粘液MUC5AC分泌,这对气道疾病中的粘液积累至关重要. 了解TMEM16A为呼吸系统疾病提供了新的治疗策略.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 异常的MUC5AC粘素分泌导致呼吸道粘液积累和阻塞在呼吸道疾病.
- 跨膜蛋白16A (TMEM16A) 越来越多地被认为是其在呼吸道上皮细胞功能中的作用.
研究的目的:
- 审查最近关于TMEM16A对呼吸道疾病中MUC5AC产生的影响的研究.
- 探索TMEM16A作为呼吸道疾病治疗点的潜力.
主要方法:
- 关于TMEM16A和MUC5AC.AC最近研究的文献综述
- 对TMEM16A在气道粘液分泌中的调节机制的分析.
- 综合与TMEM16A在呼吸道炎症和疾病中的作用相关的发现.
主要成果:
- TMEM16A在调节MUC5AC分泌方面发挥着重要作用.
- TMEM16A对MUC5AC的调节会影响粘液积累,呼吸道阻塞和炎症反应.
- TMEM16A的失调与各种呼吸道疾病的发病有关.
结论:
- TMEM16A是MUC5AC分泌的关键调节剂,是呼吸道疾病的潜在治疗标.
- 对TMEM16A机制的进一步研究可以优化呼吸系统疾病的临床治疗策略.
相关概念视频
Cystic Fibrosis: Pathogenesis
710
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
710
Cystic Fibrosis: Management
467
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
467
Drugs Used in Upper Respiratory Disorders: Overview
622
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
622
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Mucosal Barrier of the Stomach
2.0K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.0K


